“Impaired Booster-Induced SARS-CoV-2 Antibody Responses in Rituximab-Treated B-Cell Lymphoma Patients Despite Peripheral B-Cell Recovery”. 2026. Radiology and Oncology 60 (1): 76-85. https://radioloncol.com/index.php/ro/article/view/4845.